David Larsen
Stock Analyst at BTIG
(2.06)
# 2,839
Out of 4,843 analysts
73
Total ratings
33.33%
Success rate
-1.68%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Upgrades: Buy | $28 | $21.50 | +30.23% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $56.84 | -38.42% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $99.32 | +30.89% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $21.71 | +42.82% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $137.67 | +88.86% | 2 | Nov 1, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $60 → $50 | $28.77 | +73.79% | 2 | Oct 24, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $23.23 | -13.89% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $24.45 | +186.36% | 1 | Oct 3, 2024 | |
| DH Definitive Healthcare | Initiates: Buy | $7 | $3.29 | +112.77% | 1 | Sep 17, 2024 | |
| VEEV Veeva Systems | Initiates: Buy | $240 | $279.58 | -14.16% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.48 | +374.58% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $12.09 | +15.80% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.00 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $29.78 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $51.95 | - | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $7.15 | +529.37% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.55 | +491.55% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.19 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.22 | +57.52% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.77 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $95 | $5.67 | +1,575.49% | 2 | Oct 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.64 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $154.06 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $715.93 | -77.65% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.20 | +525.00% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $69.04 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $63.34 | +34.21% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $6.34 | +262.78% | 1 | Nov 2, 2017 |
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $21.50
Upside: +30.23%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $56.84
Upside: -38.42%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $99.32
Upside: +30.89%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $21.71
Upside: +42.82%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $137.67
Upside: +88.86%
Simulations Plus
Oct 24, 2024
Maintains: Buy
Price Target: $60 → $50
Current: $28.77
Upside: +73.79%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $23.23
Upside: -13.89%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $24.45
Upside: +186.36%
Definitive Healthcare
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.29
Upside: +112.77%
Veeva Systems
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $279.58
Upside: -14.16%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.48
Upside: +374.58%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $12.09
Upside: +15.80%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $29.78
Upside: -
Oct 13, 2022
Initiates: Neutral
Price Target: n/a
Current: $51.95
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $7.15
Upside: +529.37%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.55
Upside: +491.55%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $2.19
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $22.22
Upside: +57.52%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.77
Upside: -
Oct 26, 2021
Maintains: Buy
Price Target: $80 → $95
Current: $5.67
Upside: +1,575.49%
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.64
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $154.06
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $715.93
Upside: -77.65%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.20
Upside: +525.00%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $69.04
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $63.34
Upside: +34.21%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $6.34
Upside: +262.78%